Regular use of non-steroidal anti-inflammatory drugs (NSAIDs) may be protective against tumours, including breast cancer. We have studied the effects of ibuprofen and aspirin on DNA damage in lymphocytes obtained from breast cancer patients and healthy female controls. Both nanoparticle (NPs) and bulk formulations were used in the comet and micronucleus (MN) assays. Non-toxic doses (250 ng/ml ibuprofen; 500 ng/ml aspirin) were tested. Aspirin, both bulk and nano formulations, significantly reduced DNA damage measured with the comet and micronucleus assays; the nano formulation was more effective. Ibuprofen was not effective in the comet assay but showed a significant reduction in MN frequency, with the nano formulation being more effective. NPs may have better penetration through the nuclear membrane relative to the bulk formulation. NSAIDs such as aspirin and ibuprofen may have a promising role in cancer prevention and treatment.
Introduction
Breast cancer (BC) is the most common cancer affecting females worldwide [1] . BC is more common in developed countries compared to developing countries. Overall survival from BC is increasing but remains poorer in developing countries [1, 2] .
Factors in developing nations may include adaptation to Western life-styles; less BC screening; and poorer health-care [1] . BC arises from genetic and epigenetic alterations in mammary cells [3, 4] .
The effects of NSAID (ibuprofen, aspirin) use on the incidence of malignancies, including the most prevalent types (lung, prostate, colon, and breast cancers) have been studied [5, 6] . NSAID intake appears to reduce cancer risk. Daily use of NSAIDs, usually aspirin, was associated with risk reductions of 39% (BC), 63% (colon cancer), and 39% (prostate cancer). After 5 y use, NSAIDs impact became apparent, and the effect increased with duration of use [6] . Researchers have emphasized the role of NSAIDs as inhibitors of the cyclooxygenase enzymes COX-1 and COX-2, since inflammation is believed to play a role in BC.
The use of aspirin for prevention of BC is a relatively new subject of study [7] .
Protection against BC was observed in some patients who regularly took aspirin, such as patients with cardiac disease. The reduction of BC incidence was linked to inhibition of COX-1 and COX-2, with the former enzyme being inhibited more strongly. COX inhibition blocks production of prostaglandin H2 from its precursor, arachidonic acid, in turn blocking production of other of prostaglandins [7, 8] .
Inhibition of prostaglandin production inhibits their physiological roles, such as promotion of cell growth and angiogenesis, contributing to the antitumour effect of NSAIDs. Aspirin also stimulates the AMP-activated protein kinase (AMPK) signalling pathway, thereby inhibiting cancer cell growth.
Prostaglandin E2 can increase expression of aromatase, which is responsible for the biosynthesis of oestrogen. Thus aspirin may indirectly inhibit oestrogen production and associated BC growth. Nevertheless, caution should be exercised in the use of aspirin as a single agent for BC chemoprevention, due to limited available results on its protective action [7, 8] . Harris et al (1999) compared the effects of certain NSAIDs, including ibuprofen, on BC patients. Regular ibuprofen use was associated with reduction of the BC rate by about half, and it was suggested that the drug might be useful in BC prevention [9, 10] .
We have investigated the effects of aspirin and ibuprofen on genotoxicity, using lymphocytes obtained from BC patients and healthy female controls. Two different particle sizes were compared: nanoparticles (NPs) and bulk sizes. The comet assay [11] [12] [13] [14] and micronucleus (MN) genotoxicity assays [15, 16] were used.
Lymphocytes were selected for this study because they may reflect DNA damage induced by both endogenous and exogenous genotoxins, whether chemical or physical agents [17, 18] .
The comet assay (single-cell gel electrophoresis assay) can measure DNA damage [11, 19] . It is a highly sensitive method for detection of DNA cross-links and may be applied to any eukaryotic cell [20, 21] . The cytokinesis block micronucleus assay (CBMN) is the preferred method for use with human lymphocytes, since it is restricted to divided binucleate cells. MN are remnants of centric chromosome fragments or entire chromosomes. This fragment nucleus is not incorporated in the daughter nucleus [15, 16] . The CBMN is commonly used to track DNA damage in human lymphocytes [15] . ibuprofen (250 µg/ml) and aspirin (500 µg/ml), in nano and bulk formulations. The alkaline comet assay (pH >13) was performed as described previously [11] [12] [13] [14] .
Staining and comet scoring
Ethidium bromide (20 μg/ml) stain was used for DNA staining; a 60 μl aliquot of dye was added on the top of each slide and covered with a cover slip. The slides were scored under a fluorescence microscope connected to image analysis software (Andor, Belfast, UK). A 20 x magnification lens was used. 100 cells were selected randomly from each slide for analysis.
Micronucleus assay (CBMN)
Fresh blood samples from each of five healthy volunteers and five BC patients were used. Before starting the culture, T25 cm³ flasks containing 4.5 ml frozen prepared medium were placed in a 37°C incubator (5% CO 2 ) for 30 min. Sterile materials and solutions were used when performing lymphocyte 72 h cultures. The protocol was as described by Fenech [15] , [16] . 
Aspirin and ibuprofen concentrations
Two different sizes of ibuprofen and aspirin were used (NPs and bulk), using the same concentrations for both sizes. The concentration were 250 µg/ml Ibuprofen and 500 µg/ml aspirin. These concentrations were selected according to the differences in properties of the two drugs and did not cause cytotoxicity/ apoptosis (data not shown).
Cell viability
Cell viability was evaluated for lymphocytes after 30 min treatment with ibuprofen or aspirin. Cells were centrifuged in a micro-centrifuge at 450 x g for 5 min at room temperature. Then, 0.4% trypan blue solution was mixed with the cells, 1:1, and 100 cells were recorded.
Statistical analysis
Data were analysed using Graphpad and SPSS 18.0. (one-way ANOVA) and p ≤ 0.05 was considered significant.
Results
The percentages of smokers were 11% (healthy controls) and 35% BC patients. We believe that neither smoking status nor ethnicity confounded the responses, in view of the uniformity of the data; the t-test showed no significant differences between smoking status and ethnicity in the control and patient groups. Neither aspirin nor ibuprofen showed significant differences between the bulk and nano forms.
Tables 2a and b show the CBMN assay results following exposure to ibuprofen and aspirin, NPs and bulk, with respect to the cytological scoring parameters for lymphocytes from five female volunteers and five BC patients. In general, MN frequencies were reduced by both ibuprofen and aspirin.
Discussion
Various studies [5, 6] have suggested that NSAIDs can prevent tumours, including BC, and this protective effect may be mediated by pathways involving inhibition of COX1 and COX2 and the expression of tumour suppressor genes such as p53 [22, 23] . Ibuprofen and aspirin are the most commonly used NSAIDs [5, 6, 24] . In this work, ibuprofen and aspiri, NPs and bulk, were studied for their protective effect on DNA damage in BC patients, using lymphocytes as surrogate cells.
Generally, both aspirin and ibuprofen caused a reduction in DNA damage and MN formation in lymphocytes from BC patients. Aspirin, both bulk and nano sizes, gave a significant reduction in DNA damage in both the comet and MN assays. Ibuprofen, in contrast, showed a significant reduction with the MN assay, with both NPs (P≤0.001) and bulk forms (P≤0.01), but any effect in the comet assay was weak or insignificant.
Noote that the incubation times for the comet assay (30 min) and MN assay (72 h) are very different, which may explain the different results. This explanation is consistent with the fact that NPs have better penetration through nuclear membranes, due to their smaller sizes compared to the bulk form.
Ibuprofen genotoxicity has been debated. Genotoxicity of ibuprofen in
Salmonella strains was inconclusive [25] . Philipose et al [25] , on the other hand, demonstrated genotoxicity of ibuprofen in mice, namely the induction of sister chromatid exchange. Ghosh et al [26] found that ibuprofen had no genotoxic effect over a short period (two weeks) in human peripheral whole blood cells and isolated lymphocytes. Tripathi et al [27] conducted a similar study to investigate ibuprofen genotoxicity in mouse bone marrow cells. They concluded that ibuprofen has a genotoxic effect and that this effect was more pronounced at 40 and 60 mg/kg b.w.
doses than at 10 and 20.
Aspirin is not genoitoxic. A protective effect was observed in mice when aspirin (doses 0.5, 5, or 50 mg/kg b.w.) was combined with the genotoxic anticancer agent mitomycin (MMC, 2 mg/kg b.w). Aspirin reduced the genotoxocity of MMC in the liver and spleen, in a dose-dependent manner [28, 29] . These findings are in accord with the outcomes of our study. Niikawa et al. [28] suggested that aspirin many act by scavenging reactive oxygen species.
Inhibition of cyclooxygenase is the mechanism most commonly proposed for aspirin's protective activity. COX enzyme has an important function in the synthesis of prostaglandin endoperoxides. Prostanoids, including prostaglandins, are essential biological mediators and serve various biological roles. Three forms of COX are known: COX1, COX2, and COX3. Aspirin and ibuprofen can block both COX1 and COX2; their inhibition effects are greater on COX1 [30] . Prostaglandins have roles in cell division, migration, angiogenesis, and apoptosis [31] . In addition, many preclinical studies have found that the pro-inflammatory compound prostaglandin E2
(PGE2) catalyses oestrogen production by increasing expression of aromatase.
Aromatase, a cytochrome P450 enzyme, catlyzes production of oestrogen from androgens. COX enzymes stimulate PGE2 production, CYP19 transcription, and aromatase activity. These findings are consistent with the observation of a positive correlation between COX enzyme levels and CYP19 expression in human breast carcinoma [32] . The breast cancer prevention effects of aspirin and ibuprofen may be linked to inhibition of prostaglandin production and, ultimately, oestrogen production and mammary cell proliferation [7] .
Conclusions
Ibuprofen and aspirin, both bulk and NP forms, reduced comet assay DNA damage in lymphocytes from BC patients but not in healthy volunteers. The MN assay data showed a decrease in MN frequency, which followed a similar pattern to the results for the comet assay. In both assays, aspirin was more effective than ibuprofen. NPs of both agents were more effective than the bulk formulations. Our results are consistent with the hypothesis that NSAID have a promising role in BC prevention and treatment. All groups are compared to the negative control (NC), using * p = < 0.05, ** p = < 0.01, *** p = < 0.001 for significance and ns (ns) = not significant.
Table 2b
Cytological scoring parameters in lymphocytes from five BC patients following exposure to ibuprofen and aspirin (NPs and bulk). Conc = concentration NC = negative control PC = positive control NPs = nanoparticles NDI = the nuclear division index BiNC = Binucleated cells, % BiNC, is % expressed out of all types of 500 cells scored. MultiNC = Multinucleated cells % MultiNC, is % expressed out of all types of 500 cells scored. MNi = Micronuclei score/500 cells each of BiNC NPBs = nucleoplasmic bridges NBUDs = nuclear buds All groups are compared to the negative control (NC), using * p = < 0.05, ** p = < 0.01, *** p = < 0.001 for significance and ns (ns) = not significant. 
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